XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Total Assets $ 71,590,632   $ 71,590,632   $ 32,727,427
Total Liabilities 48,835,431   48,835,431   15,493,532
Net Sales 11,446,048 $ 5,875,611 32,944,217 $ 15,139,347  
Cost of Goods Sold 8,790,764 5,036,997 25,956,853 11,847,842  
Research and development 91,085 93,522 460,588 234,885  
Stock based compensation 231,854 112,451 616,660 559,980  
Selling, General and Administrative Expenses 4,782,134 3,345,567 14,953,826 10,077,558  
Loss on impairment of goodwill       1,138,203  
Hospitality Segment [Member]          
Segment Reporting Information [Line Items]          
Total Assets 12,041,295   12,041,295   9,638,828
Total Liabilities 10,731,810   10,731,810   10,666,643
Net Sales 5,715,354 4,282,030 16,944,409 9,860,392  
Cost of Goods Sold 4,454,534 4,117,717 13,895,604 8,971,628  
Research and development 0 0 0 0  
Stock based compensation 57,821 30,149 172,495 151,679  
Selling, General and Administrative Expenses 1,123,073 929,992 3,362,775 2,784,540  
Loss on impairment of goodwill       0  
Disinfectant Segment [Member]          
Segment Reporting Information [Line Items]          
Total Assets 58,169,140   58,169,140   19,831,097
Total Liabilities 29,656,765   29,656,765   1,545,217
Net Sales 5,730,694 1,593,581 15,999,808 5,278,955  
Cost of Goods Sold 4,336,230 919,280 12,061,249 2,876,214  
Research and development 91,085 93,522 460,588 234,885  
Stock based compensation 34,188 37,800 104,552 99,733  
Selling, General and Administrative Expenses 3,130,810 1,893,211 9,002,786 5,711,495  
Loss on impairment of goodwill       1,138,203  
Corporate Segment [Member]          
Segment Reporting Information [Line Items]          
Total Assets 1,380,197   1,380,197   3,257,502
Total Liabilities 8,446,856   8,446,856   $ 3,281,672
Net Sales 0 0 0 0  
Cost of Goods Sold 0 0 0 0  
Research and development 0 0 0 0  
Stock based compensation 139,845 44,502 339,613 308,568  
Selling, General and Administrative Expenses $ 528,251 $ 522,364 $ 2,588,265 1,581,523  
Loss on impairment of goodwill       $ 0